Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

NCT01352429 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
303
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Abramson Cancer Center at Penn Medicine